GLOBALIZATION AND STRATEGIC COOPERATIONS IN PHARMACEUTICAL INDUSTRY

As a result of the increasing investments required for R&D, changing structure of competition and increased competitiveness, enterprises in the pharmaceutical industry have turned to strategic alliances in order to take place in the global market and to keep pace with the developing technology. In these collaborations, acquisitions and mergers are prominent. In this study, the reasons for the strategic cooperation in pharmaceutical industry are explained and the effect of business mergers and acquisitions on performance and R&D investments has been examined through examples. In addition, the main acquisitions made in 2018 are listed